Prof. Peter Stonier , MB ChB, BSc,  PhD,  MRCPsych,  FRCP, FRCPE,  FFPM

Peter Stonier is an independent pharmaceutical physician and consultant in pharmaceutical medicine.


As a pharmaceutical physician Peter has over 35 years experience in medicines development, clinical research, life-cycle management & drug safety/pharmacovigilance. He was medical adviser, medical director & board member of the Hoechst Marion Roussel group of companies, UK (now Sanofi) between 1977 & 2000, & group medical director and QPPV of Amdipharm plc 2004-2013.

He is Director of Education & Training at the Faculty of Pharmaceutical Medicine & national Programme Director for pharmaceutical medicine specialty training for pharmaceutical & regulatory physicians in UK. He is a Board Member of the PharmaTrain Federation, developing & introducing internationally a platform of education & training for all in medicines development / clinical research: industry, academia, clinical trial investigators.

Peter was a founding Fellow of the Faculty of Pharmaceutical Medicine (FPM), Royal Colleges of Physicians UK (1989), & with others made a major contribution to achieving recognition & legal listing for the medical Specialty of Pharmaceutical Medicine in 2002.

He is visiting Professor in Pharmaceutical Medicine at King’s College London, Faculty of Life Sciences and Medicine. Whilst previously visiting professor at the University of Surrey, the first Masters programme (MSc) in Pharmaceutical Medicine / Medicines Development was introduced under his co-direction.

Peter is a past President of the FPM, a past President of IFAPP and a past President of the Royal Society of Medicine’s Section for Pharmaceutical Medicine & Research.

Peter Stonier graduated in physiology (BSc 1st Hons) with a PhD in protein chemistry (inborn errors of metabolism), Universities of Birmingham & Sheffield, UK, 1969. He studied medicine at the Manchester Medical School, qualifying with honors in 1974.

His publications include texts in pharmaceutical medicine & edited works in human psychopharmacology, clinical research, medical affairs & careers within pharmaceuticals.